Cargando…
Head‐to‐head comparison of structurally unrelated dipeptidyl peptidase 4 inhibitors in the setting of renal ischemia reperfusion injury
BACKGROUND AND PURPOSE: Results regarding protective effects of dipeptidyl peptidase 4 (DPP4) inhibitors in renal ischaemia–reperfusion injury (IRI) are conflicting. Here we have compared structurally unrelated DPP4 inhibitors in a model of renal IRI. EXPERIMENTAL APPROACH: IRI was induced in uninep...
Autores principales: | Reichetzeder, Christoph, von Websky, Karoline, Tsuprykov, Oleg, Mohagheghi Samarin, Azadeh, Falke, Luise Gabriele, Dwi Putra, Sulistyo Emantoko, Hasan, Ahmed Abdallah, Antonenko, Viktoriia, Curato, Caterina, Rippmann, Jörg, Klein, Thomas, Hocher, Berthold |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481645/ https://www.ncbi.nlm.nih.gov/pubmed/28423178 http://dx.doi.org/10.1111/bph.13822 |
Ejemplares similares
-
Linagliptin as add-on therapy to insulin for patients with type 2 diabetes
por: von Websky, Karoline, et al.
Publicado: (2013) -
DPP4 inhibition prevents AKI
por: Reichetzeder, Christoph, et al.
Publicado: (2017) -
New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors
por: Cui, Chenkai, et al.
Publicado: (2022) -
Increased global placental DNA methylation levels are associated with gestational diabetes
por: Reichetzeder, C., et al.
Publicado: (2016) -
Additional stimulation of sGC on top of standard treatment with ARB`s may offer a new therapeutic approach for the treatment of diabetic nephropathy resistant to ARB treatment alone
por: Alter, Markus, et al.
Publicado: (2011)